Danaher Corporation (DHR)
| Market Cap | 168.82B |
| Revenue (ttm) | 24.27B |
| Net Income (ttm) | 3.50B |
| Shares Out | 706.35M |
| EPS (ttm) | 4.87 |
| PE Ratio | 49.11 |
| Forward PE | 29.41 |
| Dividend | $1.28 (0.54%) |
| Ex-Dividend Date | Dec 26, 2025 |
| Volume | 3,615,902 |
| Open | 238.29 |
| Previous Close | 238.37 |
| Day's Range | 235.99 - 240.74 |
| 52-Week Range | 171.00 - 258.23 |
| Beta | 0.93 |
| Analysts | Strong Buy |
| Price Target | 250.53 (+4.82%) |
| Earnings Date | Jan 28, 2026 |
About DHR
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for man... [Read more]
Financial Performance
In 2024, Danaher's revenue was $23.88 billion, a decrease of -0.06% compared to the previous year's $23.89 billion. Earnings were $3.90 billion, a decrease of -17.79%.
Financial StatementsAnalyst Summary
According to 18 analysts, the average rating for DHR stock is "Strong Buy." The 12-month stock price target is $250.53, which is an increase of 4.82% from the latest price.
News
Danaher CEO to Comment on Financial Performance
WASHINGTON, Jan. 12, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") announced that its President and Chief Executive Officer, Rainer M. Blair, will comment tomorrow on the Compan...
The Big 3: BA, DHR, DG
Dan Deming offers a glimpse into companies outside the AI trade he sees rallying in 2026. He offers bullish perspective and example options trades for Boeing (BA), Danaher (DHR), and Dollar General (D...
Danaher Is Ready to Put Its Post-Covid Malaise Behind It
With tariff rules finalized and inventories depleted, there's light at the end of the tunnel for the medical and scientific tools manufacturer.
Danaher to Present at J.P. Morgan Healthcare Conference
WASHINGTON, Jan. 5, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that its President and Chief Executive Officer, Rainer M. Blair, will be presenting at the J.P.
Top 15 High-Growth Dividend Stocks For January 2026
My Top 15 High-Growth Dividend Stock list delivered a 0.83% gain in December, outperforming SPY and VIG. The Value-tilted portfolio variant led with a 2.17% December return, suggesting undervaluation ...
HALPER SADEH LLC ENCOURAGES DANAHER CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
Shareholders should contact the firm immediately as there may be limited time to enforce your rights. NEW YORK , Dec. 24, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is inves...
Danaher Schedules Fourth Quarter 2025 Earnings Conference Call
WASHINGTON , Dec. 17, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the fourth quarter 2025 on Wednesday, January 28, 2...
Danaher: Biotech Strength And Cash Generation Reinforce A $250 Fair Value
Danaher Corporation is rated Buy with a target price of $250, implying 10.5% upside from $226.25. DHR's strong Q3 execution featured 4.5% revenue growth, margin expansion to 37.2%, and robust free cas...
Danaher Announces Quarterly Dividend
WASHINGTON , Dec. 9, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.32 per share of its common st...
3 More Good Stocks to Invest In After Earnings
These cheap stocks from wide-moat companies look attractive today.
Danaher Corporation (DHR) Presents at Jefferies London Healthcare Conference 2025 Transcript
Danaher Corporation ( DHR) Jefferies London Healthcare Conference 2025 November 18, 2025 6:00 AM EST Company Participants Rainer Blair - President, CEO & Director Conference Call Participants Tycho P...
The Big 3: TMO, DHR, VLO
As A.I. stocks take a beating on Wednesday's trading session, Dan Deming offers his thoughts and example options trades in healthcare and energy stocks. He explains his bullish theses behind Thermo Fi...
Danaher to Present at Jefferies Global Healthcare Conference
WASHINGTON , Nov. 11, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the Jefferies Global Healthcare ...
Top 15 High-Growth Dividend Stocks For November 2025
The Top 15 High-Growth Dividend Stock list for November 2025 offers a 1.39% yield and 19.88% five-year dividend growth. Despite underperforming SPY and VIG in October, the watchlist targets a long-ter...
DHR Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher Corporation (NYSE...
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation - DHR
NEW YORK , Oct. 27, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher Co...
DHR Announcement: Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR
NEW YORK, Oct. 26, 2025 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher ...
Halper Sadeh LLC Encourages Danaher Corporation Shareholders to Contact the Firm to Discuss Their Rights
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Danaher Corporation (NYSE: DHR) breached their fiduciary duties to ...
These Analysts Increase Their Forecasts On Danaher Following Upbeat Q3 Earnings
Danaher Corporation (NYSE:DHR) reported better-than-expected third-quarter financial results on Tuesday.
Danaher: Regaining Growth Momentum
Danaher Corporation is regaining growth momentum, with strong Q3 results, positive 2026 guidance, and robust performance in its Biotechnology segment. DHR's management maintains conservative full-year...
Danaher Still A Hold: Good Q3 Results Alone Don't Make A Great Investment
Danaher Corporation reported solid Q3/25 results with 4.4% revenue growth and improved margins, yet valuation concerns persist. Despite management's optimism for high single-digit long-term growth, Da...
Danaher Corporation (DHR) Q3 2025 Earnings Call Transcript
Danaher Corporation (NYSE:DHR) Q3 2025 Earnings Call October 21, 2025 8:00 AM EDT Company Participants John Bedford - Vice President of Investor Relations Rainer Blair - President, CEO & Director Mat...
Is Danaher's Q3 beat enough to reignite long-term growth for DHR investors?
Danaher stock surged over 7% on Tuesday after the company delivered a solid third-quarter performance, with revenues rising 4.5% to $6.1 billion and non-GAAP adjusted EPS of $1.89, significantly outpa...